![](https://static.scientificamerican.com/sciam/cache/file/82102DA5-0094-40B6-BC82EBC606561A26_agenda.jpg?w=275&h=154&fit=crop)
Toward Better Pain Control
Advances in understanding the cells and molecules that transmit pain signals are providing new targets for drugs that could relieve various kinds of pain--including those poorly controlled by existing therapies...
Advances in understanding the cells and molecules that transmit pain signals are providing new targets for drugs that could relieve various kinds of pain--including those poorly controlled by existing therapies...
They could be reduced with targeted exercise and some technological innovations
The penicillin-producing Penicillium rubens originated in a moldy Illinois cantaloupe
Millions suffer from ailments such as type 1 diabetes and lupus, in which the body attacks itself
Experts explain what this treatment involves, who needs it and how to get it
Standard remedies offer little relief for the itchy rash caused by the plant, but researchers have found promising clues in the immune system
By aiming at specific genes or cells, researchers can boost effectiveness and reduce side effects
Its structural attributes and physiological effects make it an ideal tool for learning cardiology, studying heart-brain interactions and dispensing neurocardiac therapy
Innate immunity might be the key to why children have fared better with the virus. But the Delta variant poses fresh unknowns
The effects of sex hormones, X chromosomes and different gut microbes may be parts of the answer
The phenomenon triggers strong negative reactions to everyday sounds but might come from subconscious mirroring behavior
Millions of people are sickened by immune systems that are supposed to defend them. There are new ideas about why this happens and how to stop it.
Self-targeting antibodies attack part of the immune system that plays a key role in fighting infection
Rather than crystallizing all at once, kidney stones dissolve and re-form over and over
A generation of new tests could lessen overuse of antibiotics
The assay could also help evaluate organ transplants and fetal genetic disorders
Shorter courses cause fewer side effects and breed fewer antibiotic-resistant “superbugs”
The U.S.’s top infectious disease specialist describes a new Biden administration program to develop and test antivirals—and what he’s most worried about as the nation reopens...
A genomic revolution is poised to cure sickle cell and other genetic diseases
Developing pills that block the novel coronavirus has been challenging. A new Biden administration program aims to boost the effort
Support science journalism.
Thanks for reading Scientific American. Knowledge awaits.
Already a subscriber? Sign in.
Thanks for reading Scientific American. Create your free account or Sign in to continue.
Create Account